证券代码：600377 证券简称：宁沪高速 公告编号：2025-027 江苏宁沪高速公路股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、 股东会有关情况 1. 股东会的类型和届次： 2024年年度股东会 | 股份类别 | 股票代码 | 股票简称 | 股权登记日 | | --- | --- | --- | --- | | Ａ股 | 600377 | 宁沪高速 | 2025/6/20 | 二、 增加临时提案的情况说明 1. 提案人：江苏交通控股有限公司 2. 提案程序说明 公司已于 2025 年 5 月 23 日召开的第十一届董事会第十二次会议通过了《关 于本公司控股子公司江苏广靖锡澄高速公路有限责任公司（以下简称"广靖锡澄 公司"）与江苏高速新材料科技有限公司（以下简称"苏高新材公司"）签署沥 关于2024年年度股东会增加临时提案的公告 2. 股东会召开日期：2025 年 6 月 27 日 3. 股权登记日 青及新材料采购合同的日常关联交易的议案》，并拟提交公司 2024 年度股东会 审议。2025 年 6 月 ...

Summary of Ninghu Expressway Conference Call Company Overview - Ninghu Expressway reported a revenue of 23.7 billion yuan in 2024, representing an 18% year-on-year growth, with a net profit attributable to shareholders of 4.94 billion yuan and a return on equity (ROE) of 13.6% [2][3] - The company plans to distribute half of its net profit as dividends, amounting to 0.49 yuan per share (including tax), resulting in a dividend yield of approximately 3.4% [2][3] Stock Performance - Ninghu Expressway was listed on the Hong Kong Stock Exchange in 1997 and on the Shanghai Stock Exchange in 2021. The stock price has increased nearly 50 times from its historical low, while the A-share price has risen about 8 times since its listing [2][4][5] - In Q1 2024, total revenue grew by 37% year-on-year, but net profit slightly decreased by 3%, primarily due to a reduction in traffic volume [4][10] Revenue Sources - The main source of revenue for Ninghu Expressway is toll fees, accounting for 41% of total revenue, with a gross profit margin of 92% [2][6] - The renewable energy segment contributed 3% to total revenue, with a gross profit margin of 6% [2][6] - Other business segments, including financial asset investments and real estate, have a minimal impact on overall profits [2][6] Future Expansion Plans - The company plans to add new projects, including the Ningyang Yangtze River North Connection and the expansion of Ninghu Expressway, expected to open by the end of 2024, 2025, and 2028 respectively [2][7] - Ongoing construction in the southwestern section and the Guangjing North section is anticipated to commence in the second half of 2025, which will enhance the company's asset base and profitability [2][7] Capital Expenditure and Debt Management - Capital expenditures are projected to be 11.2 billion yuan in 2024 and 9.5 billion yuan in 2025, indicating a high level of investment [2][8] - The company has maintained interest-bearing liabilities exceeding 30 billion yuan for three consecutive years, posing a potential risk to profitability despite plans for debt restructuring [2][8][9] Investment Potential - Investors should monitor the growth of road assets and overall highway traffic in China. If traffic continues to rise, the company's performance may exceed the 3%-5% adjustment threshold, indicating investment value [4][11] - The company is viewed as a defensive investment, particularly during market downturns, with a current dividend yield around 3.5% [4][11]

Group 1 - The company held its 11th Board's 12th meeting on May 23, 2025, approving a proposal for a related party transaction involving the procurement of asphalt and new materials by its subsidiary Jiangsu Guangjing Xicheng Highway Co., Ltd. from Jiangsu Gaoxin Material Co., Ltd. [1] - The transaction amount is capped at RMB 311,036,849.38, which is related to two contracts for the supply of materials for highway expansion projects [2][4] - The company plans to submit this proposal for approval at the 2024 annual shareholders' meeting scheduled for June 27, 2025 [1][3] Group 2 - The shareholders' meeting will take place at 15:00 on June 27, 2025, at the company's meeting room located at 6 Xianlin Avenue, Nanjing [3] - The network voting system will be available on the Shanghai Stock Exchange, with voting times set for June 27, 2025, during specified trading hours [3] - The original shareholder meeting notice remains unchanged, and the equity registration date is also unchanged [3][4]

证券代码：600377 证券简称：宁沪高速 公告编号：2025-027 江苏宁沪高速公路股份有限公司 关于2024年年度股东会增加临时提案的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、 股东会有关情况 1. 股东会的类型和届次： 2024年年度股东会 3. 临时提案的具体内容 本公司控股子公司广靖锡澄公司与苏高新材公司、江苏省交通工程建设局 （以下简称"交建局"）开展沥青及新材料采购的关联交易。广靖锡澄公司向苏 高新材公司采购工程建设用沥青及新材料的关联交易，交易金额为不超过人民币 31,544 万元，上述议案已经本公司 2025 年 5 月 23 日召开的第十一届董事会第 十二次会议审议通过，议案的详情请见公司于 2025 年 5 月 27 日披露的《关于向 关联人采购沥青及新材料的日常关联交易公告》。 现提请股东会审议批准本公司控股子公司广靖锡澄公司根据 2025 年 6 月 9 日与苏高新材公司、交建局签署的两份附生效条件的《京沪高速公路广陵至靖江 段扩建工程沥青及新材料供应合同》及《无锡至宜兴高速公路雪堰 ...

Group 1 - Jiangsu Ninghu Expressway (600377) announced that its subsidiary, Guangjing Xicheng Company, has entrusted the construction management of the Guangjing North Section Expansion Project and the Xiyi Expressway South Section Expansion Project to the Construction Bureau [1] - Contracts for the supply of asphalt and new materials for both projects have been signed with Su Gao New Materials Company, covering the period from July 1, 2025, to July 30, 2026, for the Guangjing North Section, with an estimated cost of approximately RMB 30 million in 2025 and RMB 55.34 million in 2026 [1] - The Xiyi Expressway South Section Expansion Project has a procurement period from July 1, 2025, to December 31, 2025, with an estimated cost of approximately RMB 226 million [1] Group 2 - The transactions are routine business contracts for the company’s subsidiary, priced at market fair value, ensuring no harm to the company's interests and no related party transactions that could lead to conflicts [2] - The collaboration with Su Gao New Materials Company is expected to enhance operational efficiency and reduce management costs through synergies within the group [2] - Previous agreements between the companies have been executed effectively without any defaults, indicating a low risk of non-performance for the ongoing related transactions [2]

股票代码：600377 股票简称：宁沪高速 编号：临 2025-026 江苏宁沪高速公路股份有限公司 关于向关联人采购沥青及新材料的日常关联交易进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、本次关联交易的概述 江苏宁沪高速公路股份有限公司（以下简称"本公司"）董事会于 2025 年 5 月 23 日审议批准《关于本公司控股子公司江苏广靖锡澄高速公路有限责任公 司（以下简称"广靖锡澄公司"）与江苏高速新材料科技有限公司（以下简称"苏 高新材公司"）签署沥青及新材料采购合同的日常关联交易议案》，同意本公司 控股子公司广靖锡澄公司与苏高新材公司、江苏省交通工程建设局（以下简称"交 建局"）开展沥青及新材料采购的关联交易，广靖锡澄公司向苏高新材公司采购 工程建设用沥青及新材料，合同金额不超过人民币 31,544 万元。该关联交易尚 需提交股东大会审议批准。 有关详情请参见本公司于 2025 年 5 月 27 日在《中国证券报》《上海证券报》 《证券时报》以及上海证券交易所网站 www.sse.com.cn、香港联合交易 ...

此乃要件 請即處理 閣下如對本通函的任何方面或應採取的行動有任何疑問，應諮詢 閣下的股票經紀或其他註 冊證券商、銀行經理、律師、專業會計師或其他專業顧問。 閣下如已將所屬的江蘇寧滬高速公路股份有限公司的股份全部售出，應立即將本通函及隨附 的代表委任表格及股東回執送交買主，或經手買賣的銀行、股票經紀或其他代理商，以便轉 交買主。 香港交易及結算所有限公司及香港聯合交易所有限公司對本通函之內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示，概不對因本通函全部或任何部份內容而產生或 因依賴該等內容而引致之任何損失承擔任何責任。 JIANGSU EXPRESSWAY COMPANY LIMITED 江蘇寧滬高速公路股份有限公 司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：00177） (1) 建議發行中期票據 (2) 發行股份的一般授權 及 (3) 2024年年度股東大會通知 茲定於2025年6月27日（星期五）下午3時正在中國南京市仙林大道6號舉行2024年年度股東大會， 大會通知載於本通函第N-1頁至第N-9頁。無論 閣下是否能出席大會，務請盡快將隨附投票 代理委託書，按照其列印的指示填 ...

证券代码：600377 证券简称：宁沪高速 公告编号：2025-025 江苏宁沪高速公路股份有限公司 关于召开2024年年度股东会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (一)股东会类型和届次 2024年年度股东会 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025 年 6 月 27 日 15 点 00 分 召开地点：南京市仙林大道 6 号公司会议室 股东会召开日期：2025年6月27日 本次股东会采用的网络投票系统：上海证券交易所股东大会网络投票系 统 (二)股东会召集人：董事会 (三)投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合的方 式 (五)网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 6 月 27 日 至2025 年 6 月 27 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东会召开当日的交易时间段，即 9:15-9:25,9:3 ...

Core Viewpoint - Jiangsu listed company Ninghu Expressway (600377.SH) plans to increase capital for its subsidiary to accelerate project construction [1][2] Group 1: Capital Increase and Project Details - Ninghu Expressway announced a capital increase of approximately 2.497 billion yuan for its subsidiary Jiangsu Xitai Expressway Co., Ltd. [1] - The company has been approved to invest in the Wuxi to Taicang Expressway, with a total project investment of about 24.198 billion yuan [2] - The capital increase will result in Ninghu Expressway holding 47.50% of Xitai Company after the investment [2][6] Group 2: Financial Performance and Strategy - Since its listing in 2001, Ninghu Expressway has accumulated profits of 62.553 billion yuan and cash dividends of 41.209 billion yuan, with a dividend payout ratio of 65.88% [4][10] - The company has maintained a net profit exceeding 2 billion yuan for 16 consecutive years, indicating strong financial performance [8][10] - Ninghu Expressway has a total asset value of approximately 89.886 billion yuan and a net asset value of about 38.597 billion yuan [8] Group 3: Market Position and Competitive Advantage - Ninghu Expressway is one of the largest listed companies in the domestic highway industry, with significant experience in investment, construction, operation, and management of transportation infrastructure [4][9] - The company operates in the dynamic Yangtze River Delta region, controlling or participating in approximately 1,000 kilometers of expressway projects [8][9] - The introduction of social capital is expected to accelerate the construction progress of the Xitai project, enhancing the company's position in the southern Jiangsu highway network [7][6]

Group 1 - Guangdian Electric's wholly-owned subsidiary plans to sell 5.91% stake in Shanghai Winshun Electric Technology Co., Ltd. to Yapp Automotive Parts Co., Ltd. for 62.63 million yuan, aiming to optimize asset structure [1] - Anhui Natural Gas received approval for the registration of 500 million yuan short-term financing bonds and 600 million yuan medium-term notes, valid for two years [1] - Kirin Security received government subsidies totaling 6.48 million yuan, which are related to revenue [2] Group 2 - Junshi Biosciences received approval for two new indications for its self-developed drug, Oncorhynchus monoclonal antibody injection, targeting adult patients with heterozygous familial hypercholesterolemia and non-familial hypercholesterolemia [3] - China Resources Double Crane's subsidiary passed GMP compliance inspection for small and large volume injection production lines [4] - Nanjing Public Utilities' board approved the absorption and merger of its wholly-owned subsidiary, Nanjing Jinguang Industry Co., Ltd. [7] Group 3 - Boya Bio received drug registration certificate for human immunoglobulin (pH4) in the Dominican Republic, valid until August 12, 2029 [8] - Jizhi Co. announced that its controlling shareholder and actual controller committed not to reduce their shareholdings until December 31, 2025 [9] - Yuhua Tian won a bid for the integrated urban management project in Lanzhou City, with a total service subsidy of 353 million yuan [10] Group 4 - Anke Rui obtained five invention patent certificates related to various energy management and control technologies [11] - Kebo Da's wholly-owned subsidiary plans to acquire 100% of Czech IMI Company for approximately 9.43 million euros to enhance global production layout [13] - Yantian Port announced a cash dividend of 1.30 yuan per 10 shares, totaling 676 million yuan [14] Group 5 - Huawang Technology plans to distribute a cash dividend of 0.45 yuan per share and a capital reserve increase of 0.20 shares per share [15] - Kabe Yi established a wholly-owned subsidiary in Japan to enhance its business layout [16] - Dongcheng Pharmaceutical's subsidiary received approval for the marketing of sodium fluoride injection, a PET radiopharmaceutical [18] Group 6 - Huaxin New Materials' subsidiary received two utility model patent certificates for innovative devices [19] - Lingang Steel's new 2290 cubic meter blast furnace has been successfully put into operation [21] - Xinlitai received drug registration certificate for Sacubitril/Valsartan tablets, the first of its kind in China [23] Group 7 - Aike Co.'s subsidiary received project designation notices from multiple clients for electric drive platform components [25] - Tonghe Pharmaceutical received drug registration certificate for Apixaban in South Korea [26] - Junting Hotel signed a cooperation agreement with Choice Hotels for exclusive brand usage in mainland China [28] Group 8 - Guangdong Hongtu plans to establish a wholly-owned subsidiary in Zhengzhou to enhance market layout [30] - Yuheng Pharmaceutical signed a joint promotion agreement for Pemafibrate tablets with Xinghe Pharmaceutical [31] - Chongqing Steel terminated the absorption and merger of its wholly-owned subsidiary, citing strategic advantages of independent operation [33] Group 9 - Jihong Co. announced the listing of its H-shares on the Hong Kong Stock Exchange [34] - Deshi Co. announced plans for shareholders to reduce their holdings by up to 0.3% [36] - Xinhai Medical's subsidiary received medical device registration for a dialysis fluid filter [42]